> top > docs > PMC:7205724 > spans > 503-615 > annotations

PMC:7205724 / 503-615 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
17 30-33 Gene denotes IL6 Gene:3569
18 89-92 Gene denotes IL6 Gene:3569
19 57-65 Species denotes patients Tax:9606
20 9-20 Chemical denotes Tocilizumab MESH:C502936
21 71-79 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T5 71-79 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T5 71-79 Species denotes COVID-19 NCBItxid:2697049

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T9 6-93 Sentence denotes • Tocilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high IL6.
T10 95-103 Sentence denotes Abstract

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
20 9-20 Chemical denotes Tocilizumab MESH:C502936
17 30-33 Gene denotes IL6 Gene:3569
19 57-65 Species denotes patients Tax:9606
21 71-79 Disease denotes COVID-19 MESH:C000657245
18 89-92 Gene denotes IL6 Gene:3569

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T45 30-33 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0
T89 89-92 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T75 6-7 IN denotes •
T76 9-20 NNP denotes Tocilizumab
T77 20-21 -COMMA- denotes ,
T78 22-24 DT denotes an
T79 25-33 NN denotes anti-IL6
T80 33-34 -COMMA- denotes ,
T81 35-38 MD denotes can
T82 39-45 VB denotes confer
T83 46-53 NN denotes benefit
T84 54-56 IN denotes in
T85 57-65 NNS denotes patients
T86 66-70 IN denotes with
T87 71-79 NN denotes COVID-19
T88 80-83 CC denotes and
T89 84-88 JJ denotes high
T90 89-92 NN denotes IL6
T91 95-103 NN denotes Abstract
T92 104-107 DT denotes The
R69 T82 T75 arg1Of confer,•
R70 T76 T77 arg1Of Tocilizumab,","
R71 T79 T77 arg2Of anti-IL6,","
R72 T79 T78 arg1Of anti-IL6,an
R73 T82 T80 arg1Of confer,","
R74 T76 T81 arg1Of Tocilizumab,can
R75 T82 T81 arg2Of confer,can
R76 T76 T82 arg1Of Tocilizumab,confer
R77 T83 T82 arg2Of benefit,confer
R78 T82 T84 arg1Of confer,in
R79 T85 T84 arg2Of patients,in
R80 T85 T86 arg1Of patients,with
R81 T88 T86 arg2Of and,with
R82 T87 T88 arg1Of COVID-19,and
R83 T90 T88 arg2Of IL6,and
R84 T90 T89 arg1Of IL6,high

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T5 71-79 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T9 6-93 Sentence denotes • Tocilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high IL6.
T10 95-103 Sentence denotes Abstract